Engineered T-cells may kill off reservoir cells, mimicking elusive CD8 vaccine effect
Resistance is a growing concern amid rising use of doxyPEP
“We will not go back!”: a powerful, resolute response to funding cuts at IAS 2025
Rwanda’s HIV leadership on display at IAS 2025
Coming soon: news from IAS 2025
Are automated campaigns driven by AI the future of HIV prevention?
Two doses of HPV vaccine as effective as the recommended three-dose schedule for women with HIV
Women with HIV have no cardiovascular advantage over men, unlike in the general population
Climate change is threatening the sexual health of young adolescents in Kenya
